Logo

William Blair

William Blair Downgrades Lucira Health to Market Perform

As a result of the downgrade, the bank also significantly reduced revenue and volume estimates for 2021 and 2022.

William Blair Initiates Coverage of 10x Genomics With Outperform Rating

Analysts for the investment bank, which co-managed a recent 10x stock offering, said the company could "redefine the way biological analysis is performed."

Roche to Acquire GenMark Diagnostics for $1.8B

Under the acquisition agreement, expected to close in Q2, Roche will acquire all outstanding shares of GenMark's common stock for $24.05 per share.

10x Genomics Prices Upsized $440M Public Offering

The firm is offering an additional 500,000 shares of Class A stock, bringing the total to 4 million shares, offered at $110 per share.

10x Genomics to Sell 3.5M Shares in Public Offering

The single-cell and spatial genomics firm is seeking to raise more money from the markets a year after its $410.8 million IPO.

Aug 11, 2020

JP Morgan, Cowen, William Blair Initiate Coverage of Berkeley Lights

Jul 16, 2020

Adaptive Biotechnologies to Raise $240M in Public Stock Offering

May 11, 2020

William Blair Upgrades Meridian Bioscience to Outperform

Jan 24, 2020

Adaptive Biotechnologies Prices Public Offering of Stock

Jan 21, 2020

Adaptive Biotechnologies Announces Preliminary FY19 Revenue Increase, $257M Stock Offering

Jul 26, 2018

Veracyte Prices $51.3M Public Offering

Jan 5, 2018

Illumina Remains NGS Leader But Competitors Expected to Gain, Survey Finds
Premium

Jul 18, 2017

Investment Banks Upgrade Quidel Shares on Acquisition of Alere Assets

May 21, 2015

Investment Banks Downgrade Bruker on Resignation of CFO

May 1, 2015

William Blair Upgrades PacBio Shares on Technology Improvements, Expanded Applications

Apr 21, 2015

Survey Finds High Interest in Long-Range Genome Data, Nanopore Tech While Illumina Rules NGS Market
Premium

Jan 20, 2015

Investment Banks Upgrade Fluidigm, Hologic

Jun 23, 2014

William Blair Upgrades Sequenom to Outperform

Aug 2, 2013

Piper Jaffray Upgrades PacBio Following Earnings Results

Jul 25, 2013

William Blair Downgrades Sequenom, Citing Coding Issues and Increased Competition; Shares Down Sharply

Jul 19, 2013

William Blair Begins Coverage of Waters with Market Perform Rating

Jan 22, 2013

Analysts Speculate on Potential Life Technologies Sale

Oct 25, 2012

Survey Indicates Life Tech Remains Leader of qPCR Research Market, But Faces Some Pricing Pressure
Premium

Sep 25, 2012

William Blair Initiates Coverage of Life Tech with Outperform

May 29, 2012

William Blair Downgrades Complete Genomics

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.